sees in Biological Technology

Cord Blood America Sees Significant Positives in President Obama's Lifting of Stem Cell Funding Restrictions

SANTA MONICA, Calif., March 9 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company ( http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells to families nationwide and internat...

Frost & Sullivan Sees Microdosing as Compelling Advantage for Big Pharma

LONDON, Feb. 10 /PRNewswire/ -- Microdosing or Phase 0 clinical testing has been gaining acceptance and might become an imperative phase of the drug development process in the years to come. The emergence of niche capability providers in preclinical testing and technology dependence is also expect...

National Ergonomics Expo Sees 86% On-Site Exhibitor Renewal Rate for 2009; New Products from Contour Design, Equipois, Goldtouch and Herman Miller Win 2008 NECE Attendees' Choice New Product Awards

NEW YORK, Dec. 10 /PRNewswire/ -- The 14th Annual National Ergonomics Conference and Exposition (NECE) at Caesars Palace, Las Vegas, Dec. 2 - 5 was yet again the largest annual gathering of ergonomics decision makers and ergonomics product sellers held in the U.S. with over 1,200 attendees represe...

Monsanto Sees Growing Opportunity for Biotech Traits Globally

R&D Pipeline Products Poised to Deliver Yield Benefits and Value to Farmers LONDON, Sept. 11 /PRNewswire-FirstCall/ -- Monsanto Company (NYSE: MON ) sees a significant growth opportunity in continuing to create more yield for farmers worldwide through its investment in plant biotechnology and b...

Elekta Sees Record Attendance and Record Number of Submitted Abstracts at International Leksell Gamma Knife(R) Society Meeting in Quebec, Canada

STOCKHOLM, Sweden, May 21 /PRNewswire/ -- At the 14th International Leksell Gamma Knife(R) Society Meeting on May 18-22, over 500 participants including neurosurgeons, radiation oncologists and other medical specialists using Leksell Gamma Knife for treatment of tumors and other brain disorder...

Signalife Sees Accretive Purchase and Financial Commitments

LOS ANGELES, March 17 /PRNewswire-FirstCall/ -- Signalife, Inc. (Amex: SGN - News) announced earlier today that it has received several formal purchase and financial commitments with respect to acquisitions of the Company's technology licenses, devices and services. These commitments have come...

Newly Appointed Dilon Technologies President & CEO Robert G. Moussa Sees BSGI as ' ... Major Weapon in the Battle Against Cancer'

NEWPORT NEWS, Va., Feb 7 /PRNewswire/ -- Dilon Technologies, makers of a gamma imaging system optimized for early breast cancer detection, has appointed Robert G. Moussa to the position of President and Chief Executive Officer. Moussa has a long and successful record in the medical device in...

Survey Sees Mass. CEOs as Bullish on Own Businesses

High Expectations for Biotech Plan LOWELL, Mass., Oct. 11 /PRNewswire-USNewswire/ -- More than half of Massachusetts CEOs are somewhat optimistic about their own companies, but are concerned about the current state and national economies, according to a new statewide poll of 500 CEOs release...

Monsanto Sees Record Sales in Fiscal Year 2007; Seeds and Traits Business Contributes to Strong Fourth Quarter and Year-End Results

ST. LOUIS, Oct. 10 /PRNewswire-FirstCall/ -- Fourth Fourth Fiscal Fiscal ($ in millions) Quarter Quarter Year Year 2007 2006 2007 2006 Net Sales by Segment Cor...

Investor profile: Peter M. Skanavis, tech angel, sees investing as civic duty

MILWAUKEE Before a technology entrepreneur can raise the seed capital he needs to fuel his rapidly growing business, he needs to identify one or more individuals who are legally allowed to make angel investments. This is not an easy thing to do. But fortunately for southeastern Wisconsins tec...

Milwaukee research alliance sees need for incubator

The Milwaukee County Research Park could see some competition soon. A coalition of research and metropolitan groups in the Milwaukee area is making plans for an incubator for start-up biotech companies. The Milwaukee County Research Park is straining to fit new companies in, said representa...

PDS sees Madison facility as launchpad for growth

Madison, Wis. -- Paragon Development Systems is poised for significant growth with the opening of its new Madison office to house the company's 24/7 service desk, the company's founder said Monday. The Oconomowoc, Wis.-based company, which is an IT infrastructure services provider, officially ...

UW engineering career fair sees highest attendance in four years

Madison, Wis. - At least 3,600 University of Wisconsin-Madison engineering students looking to enter the job market descended on the Engineering Centers building last week for the semiannual Career Connection Fair. Sponsored by UW-Madison's Engineering Career Services , the fair brought at ...

Republican sees nothing wrong with Doyle's use of executive order

Brookfield, Wis. A key lawmaker who often disagrees with Governor Jim Doyle on embryonic stem cell research said Wednesday that he saw nothing inappropriate about the governor's use of an executive order as an instrument to fund the recruiting of stem cell companies. Meanwhile, the executive ...

TomoTherapy sees sustained market advantage

Madison, Wis . - Fred Robertson doesn't pretend to be a fortune teller, but he believes his company, TomoTherapy, will be setting the standard in radiation therapy for some time to come. Robertson, chief executive officer of TomoTherapy, exudes confidence that the Hi-Art System, the company's...

Small-business trends: Intuit sees more mom-preneurs

Madison, Wis. - Expect the face of small business to continue its transformation over the next decade, as the entrepreneurial class diversifies to an even greater degree, according to a Part I of a report on the future of small business sponsored by Intuit , the California-based provider of bu...

Visions, Part II: Preizler sees IT leading incremental health system change

Editor's note: This is the second of a two-part interview with Marty Preizler, president and CEO of Physicians Plus Insurance Corp. In Part I , he provided an insurer's view of healthcare IT and patient data exchange. WTN : We hear a lot about interoperability of information technology sy...

Patent Attorney John Rizvi Speaks at FIME International Medical Expo

...ors from overseas and nationally are launching knock-off products based on a patent holder's intellectual property. John Rizvi said that he often sees companies work with attorneys who don't fully understand the medical patent industry and draft claims that are too narrow in scope. This can allow a ...

Stanford researchers find a quicker, cheaper way to sort isotopes

...monstrate the viability of their technique. "My goal is to become better than and actually replace isotope ratio mass spectrometry," Zare said. He sees this as a possibility within the next 5 to 10 years. ...

Genomic Health Reports Favorable Commentary on Value of Multigene Assays From the St. Gallen Expert Consensus Meeting on the Primary Treatment of Early Breast Cancer

...e the indication for adjuvant chemotherapy is uncertain. "These new guidelines provide further evidence that the international clinical community sees the value of advanced molecular diagnostics in helping make more informed, individualized breast cancer treatment decisions," said Dr. Joseph Gligorov...

European Airports Actively Engaging on Reducing CO2, Despite the Crisis

...editation at the 19th ACI EUROPE Annual Congress taking place in Manchester sees ACI EUROPE deliver on that promise, at a critical time. Airport Carbon...on the airport site. Today's launch of the programme - which is voluntary - sees a total of 31 European airports applying for Airport Carbon Accreditation. ...

Mylan Again Calls for an End to Authorized Generics During 180-Day Exclusivity Period

... sees opportunity to end abusive use of authorized generics during period of exclusivity PITTSBURGH, June 3 /PRNewswire-FirstCall/ -- Mylan Inc.'s (Nas...

Plexus Awarded Development Contract With QIAGEN

...pairs two world-class companies to create an industry leading product," stated Steve Frisch, Sr. Vice President, Global Engineering Services. "Plexus sees this relationship as an indication of how we can utilize our full suite of engineering capabilities, coupled with our complete Product Realization Se...

ChemDiv Group Acquires Prudentas Through ChemRar High Tech Center

...in response to a growing interest of ChemDiv's pharmaceutical and biotech partners in conducting quality and expeditious clinical trials. ChemDiv sees great potential in this acquisition by adding value to ChemDiv's Discovery outSource(TM) services offered to pharmaceutical and biotech companies worl...

ChemAxon Launches Marvin and JChem Version 5.2; Web Services, native .NET API, Homology Groups, 3D Alignment and Structural Frameworks

...re solutions provider for cheminformatics today announced the launch of version 5.2 of their cheminformatics toolkits, Marvin & JChem. The release sees many new functionalities added, new integration options and improvements in search performance. Marvin & JChem is a software suite of appli...

Siemens Focuses on Role-Based, Context-Sensitive, and Knowledge-Driven Solutions at HIMSS 2009

...and previous imaging studies, previous reports, lab values, and allergies, as well as scanned documents all in one application window. The radiologist sees this information without having to access various separate systems at multiple locations. Task-specific tools and information are available with just ...

ArunA Biomedical Submits Contract Proposal to Further Develop Environmental Biosensor for National Security

...search for use in drug discovery and basic research. ArunA is the first company to commercialize products derived from human embryonic stem cells and sees its proprietary technology as a catalyst leading to the discovery of novel therapeutic compounds, tests for neurotoxicity and breakthroughs in underst...

ArunA Biomedical Awarded Department of Defense Contract to Further Develop Environmental Biosensor for National Security

...search for use in drug discovery and basic research. ArunA is the first company to commercialize products derived from human embryonic stem cells and sees its proprietary technology as a catalyst leading to the discovery of novel therapeutic compounds, tests for neurotoxicity and breakthroughs in underst...

ArunA Biomedical Announces Co-development of Fully Validated Induced Pluripotent Stem Cell Kit

...search for use in drug discovery and basic research. ArunA is the first company to commercialize products derived from human embryonic stem cells and sees its proprietary technology as a catalyst leading to the discovery of novel therapeutic compounds, tests for neurotoxicity and breakthroughs in underst...

ArunA Biomedical Announces Commercial Release of its Human Embryonic Stem Cell Derived Mesenchymal Cells

...search for use in drug discovery and basic research. ArunA is the first company to commercialize products derived from human embryonic stem cells and sees its proprietary technology as a catalyst leading to the discovery of novel therapeutic compounds, tests for neurotoxicity and breakthroughs in underst...

First Application to Fight High Cholesterol Launches on the iPhone and iPod Touch

... easy-to-understand language. "The objective of the application is to motivate people to lower their cholesterol and keep it low. If the user sees that reducing their fat intake, exercising regularly and giving up smoking has a positive impact on their cholesterol then these positive lifestyle ch...

While Most Companies and Industries Struggled in 2008, LifeModeler, Inc. Used Unique Products to Post Aggressive Business Gains in All Areas

...re endowments this year, which together amount to nearly $1 million. McGuan sees expansion of these support programs as being key to maintaining his industr...r both Mars and lunar landing projects. Back on earth, the company CEO sees no let-up in the pace that he and his staff have set in the past year. He ...

Monsanto Executives to Discuss Company's Growth Drivers, Profit Goals at Investor Conferences in February

...l/ -- On the heels of a strong start to fiscal 2009, Monsanto Company (NYSE: MON ) executives will explain to investors this month where the company sees its opportunities for continued growth through the rest of this year and how it plans to achieve its goal of more than doubling its fiscal 2007 gross ...

Stanford writes in world's smallest letters

...sement lab in the Varian Physics Building, Manoharan and Moon began their writing project with a scanning tunneling microscope, a device that not only sees objects at a very small scale but also can be used to move around individual atoms. The Stanford team used it to drag single carbon monoxide molecules...

ArunA Biomedical Announces Commercial Release of its Human Embryonic Stem Cell Derived Neural Cells

...search for use in drug discovery and basic research. ArunA is the first company to commercialize products derived from human embryonic stem cells and sees its proprietary technology as a catalyst leading to the discovery of novel therapeutic compounds, tests for neurotoxicity and breakthroughs in underst...

A supercharged metal-ion generator

...ion of ions also helps deposition reach into the narrowest crevices of the negatively charged substrate. Beyond the semiconductor industry Anders sees a wide range of applications for the efficient new process, some of which may sound exotic. Because a sustained, self-sputtering plasma can operate in...

SAFC Pharma Augments Assay Development Capabilities

...FC's continued commitment to building capabilities in important emerging new technologies such as viral vaccines and gene therapies - areas where SAFC sees great potential. As new and increasingly complex products make their way to commercialization, SAFC will continue to be strongly positioned to collabo...

Smallest ever quantum dots bring real world applications closer

... single atom quantum dots have also demonstrated another advantage significant control over individual electrons by using very little energy. Wolkow sees this low energy control as the key to quantum dot application in entirely new forms of silicon-based electronic devices, such as ultra low power compu...

YM BIOSCIENCES' NIMOTUZUMAB SELECTED FOR MULTINATIONAL PHASE III TRIAL BY NATIONAL CANCER CENTRE OF SINGAPORE

... National Cancer Centre Singapore is the premier cancer research and treatment facility in Singapore and in the region. It was established in 1997 and sees more than 60 percent of the public sector medical oncology cases and about 70 percent of radiation oncology cases. For more information, visit NCCS we...

EcoSphere(R) Biolatex(TM) Secures Funding from Granholm and Invest Michigan!

...; states Richard Shatkosky, President of EcoSynthetix. "With the wildly fluctuating price of petroleum products in the market, the paper industry sees EcoSphere biolatex as a way to provide some stability in their production process." EcoSphere biolatex is a starch based product that is us...